Fig. 2
From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma
Kaplan-Meier estimate of Upper Tract Urothelial Carcinoma related mortality in patients who received 5α-reductase inhibitor and nonuser
Fig. 2 | BMC Cancer